Liquidia Corporation (LQDA) Investor Relations Documents

Liquidia Corporation (LQDA) investor relations documents from the company's IR site: 6 presentations, 34 press releases; latest deck 2026-08-11. Read in-app with summaries. First-party data.

View Presentation: Liquidia Corporation's Q2 2026 earnings report highlights YUTREPIA's commercial growth, reaching $170.4 million in net product sales and $74.7 million in net income.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-09-03Press releasePress release
2026-09-03Press releaseFDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclero
2026-09-02Press releasePress release
2026-08-11PresentationView Presentation
2026-08-12Press releasePress release
2026-08-12Press releaseLiquidia Corporation Reports Second Quarter 2026 Financial Results
2026-07-29Press releasePress release
2026-07-29Press releaseLiquidia Corporation to Report Second Quarter 2026 Financial Results on August 12, 2026
2026-06-11Press releasePress release
2026-06-11Press releaseLiquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions
2026-06-08Press releasePress release
2026-06-08Press releaseLiquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index
2026-05-27Press releasePress release
2026-05-27Press releaseLiquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference
2026-05-10PresentationView Presentation
2026-05-11Press releasePress release
2026-05-11Press releaseLiquidia Corporation Reports First Quarter 2026 Financial Results
2026-05-06Press releaseLiquidia Corporation to Participate in Upcoming Investor Conferences
2026-05-04Press releasePress release
2026-05-04Press releaseLiquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026
2026-04-07Press releasePress release
2026-04-07Press releaseLiquidia Corporation to Participate in Upcoming Investor Conferences
2026-03-05PresentationView Presentation
2026-03-05Press releasePress release
2026-03-05Press releaseLiquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
2026-02-26Press releasePress release
2026-02-26Press releaseLiquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026
2026-01-27Press releasePress release
2026-01-27Press releaseLiquidia to Present Clinical Data Across Its Portfolio at the Pulmonary Vascular Research Institute 2026 Annual Congress
2026-02-03PresentationView Presentation
2026-01-09Press releasePress release
2026-01-09Press releaseLiquidia Corporation Announces Preliminary Full-Year 2025 YUTREPIA Net Sales and Corporate Update
2026-01-07Press releasePress release
2026-01-07Press releaseLiquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference
2025-11-02PresentationView Presentation
Press releaseLiquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update
2025-11-03Press releasePress release
2025-11-03Press releasePress release
2025-11-03Press releaseLiquidia Corporation to Present at Upcoming Healthcare Investment Conferences
2026-02-03PresentationView Presentation

LQDA overview · LQDA earnings · LQDA financials · LQDA KPIs · LQDA documents · LQDA ownership · LQDA peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.